ANT-GROUP
20.5.2021 09:39:09 CEST | Business Wire | Press release
Ant Group today released its 2020 Sustainability Report, highlighting its key activities, achievements and progress in bringing inclusive development and environmental sustainability to the world through digital technology.
This press release features multimedia. View the full release here: https://www.businesswire.com/news/home/20210520005402/en/
In 2020, Covid-19 transformed the way people live and work. The report outlines Ant’s efforts to support Small and Micro Enterprises (SMEs) in their pandemic recovery, strengthen financial inclusion, bridge digital inequality, and promote sustainability.
“Ant Group remains committed to its mission of using technology to provide ordinary people and small businesses with more equal access to financial and daily life services,” said Ant Group’s Chairman and Chief Executive Officer Eric Jing. “As we face the challenges of today, we feel an even greater sense of responsibility and will strive to explore better solutions to serve the development of society.”
Working with its partners, Ant Group is continuing to build a future that is more inclusive, green, and sustainable, by reducing financing costs for SMEs and micro businesses and developing rural economies, investing in green technologies, and working to further protect the interests of consumers.
Key highlights from the 2020 Sustainability Report are enclosed below.
Supporting Small and Micro Enterprises
In 2020, MYbank, a leading online private commercial bank and an associate of Ant Group, served 35 million SMEs and individually-owned businesses, of which 80% were first-time borrowers of any business loans, while keeping the default rate at a low level.
MYbank’s initiatives to support SMEs’ pandemic recovery included:
- Providing low-interest and interest-free loans to 8.5 million digital shops and small stores in Hubei Province.
- Issuing RMB 10 billion in interest-free loan vouchers to businesses in 81 Chinese cities to support the recovery of small shops.
- Offering a free "zero-billing period" on advance payment services to e-commerce businesses, providing advance payments of more than RMB 200 billion
Adopting and Encouraging Green Initiatives
- In 2021, Ant announced its carbon neutrality goals and corresponding action plans, pledging to achieve carbon neutrality by 2030.
- The company also put forward a series of intermediary goals, including a 30% reduction in absolute emissions in Scope 1 and Scope 2 by 2025 (compared with 2020), a full assessment of its supply chain emissions, and a full transition to renewable energy for its leased data center services. Ant Forest, a tree-planting mini program in the Alipay app where users earn points for making low-carbon lifestyle choices, attracted over 550 million users to plant more than 220 million real trees, helping reduce carbon emissions by more than 12 million tons as of December 2020.
Creating Opportunities for Women
- Launched in late 2019, Ant’s A-Idol Initiative brought employment opportunities to women in less-developed areas, with women accounting for at least 60% of the employees of social enterprises incubated by the initiative.
- As part of its "Wind Rider” project, Ant funded 40 women’s football teams in rural schools to provide women with more opportunities for education and personal development through football.
- On July 15, 2020, Ant launched the "Cyber Mulan" program, which aims to assist 50 million women globally within five years, enhancing women's participation and competitiveness in the digital economy.
Access the full report here: https://www.antgroup.com/en/news-media/media-library?type=Sustainability%20Report
About Ant Group
Ant Group aims to create the infrastructure and platform to support the digital transformation of the service industry. Ant Group strives to enable all consumers and small and micro businesses to have equal access to financial and other services that are inclusive, green and sustainable.
View source version on businesswire.com: https://www.businesswire.com/news/home/20210520005402/en/
About Business Wire
Subscribe to releases from Business Wire
Subscribe to all the latest releases from Business Wire by registering your e-mail address below. You can unsubscribe at any time.
Latest releases from Business Wire
FPT Named an OpenAI Select Partner6.8.2026 02:00:00 CEST | Press release
Global IT corporation FPT today announced that it has been named an OpenAI Select Partner within the OpenAI Partner Network. This press release features multimedia. View the full release here: https://www.businesswire.com/news/home/20260805503787/en/ FPT Named an OpenAI Select Partner The OpenAI Partner Network is a global program for partners to build, sell, and deliver AI solutions with OpenAI. It brings together partners with deep industry expertise, delivery capabilities, and customer relationships while equipping them with resources, enablement, and support to help enterprises adopt OpenAI frontier models and products and turn them into measurable impact. As an OpenAI Select Partner, FPT will continue working with OpenAI to help organizations build, deploy, and scale AI solutions responsibly and effectively. This work will help organizations get more useful work from every token and stronger performance per dollar with GPT‑5.6, while using ChatGPT Work to turn ambitious goals into
U.S. FDA Approves Takeda’s ORZEYFUL™ (oveporexton), the First and Only Medicine to Treat the Underlying Cause of Narcolepsy Type 16.8.2026 00:10:00 CEST | Press release
Adults Taking ORZEYFUL Experienced Significant and Meaningful Improvements Across the Full Range of Symptoms of Narcolepsy Type 1 (NT1) in Clinical Trials Compared to Those on Placebo As a First-in-Class Orexin Treatment, ORZEYFUL has the Potential to Redefine NT1 Care Beyond Individual Symptoms Takeda is Advancing U.S. Launch Preparations and Expects to Make ORZEYFUL Available Following Completion of the Drug Enforcement Administration (DEA) Scheduling Process Takeda (TSE:4502/NYSE:TAK) announced that the U.S. Food and Drug Administration (FDA) approved ORZEYFUL™ (oveporexton), an oral orexin receptor 2 (OX2R) agonist, for the treatment of narcolepsy type 1 (NT1, narcolepsy with cataplexy) in adults.* The persistent 24-hour nature of NT1 is driven by orexin deficiency and can severely impact people’s lives. As a first-in-class orexin treatment, ORZEYFUL is the only medicine indicated in the U.S. to treat the disease holistically rather than individual symptoms. “The FDA approval of OR
Compass Pathways Announces New Employee Inducement Grants Under Nasdaq Listing Rule 5635(c)(4)5.8.2026 22:30:00 CEST | Press release
Compass Pathways plc (Nasdaq: CMPS), a biotechnology company dedicated to unlocking urgently needed new treatment options in mental health care, announced today that Compass granted equity awards under the Compass Pathways plc 2026 Inducement Plan to fourteen newly hired non-executive employees. The equity awards were granted on August 3, 2026 and consisted of options to purchase an aggregate of 139,355 shares and restricted share units or, in the case of employees in the United Kingdom nominal cost options, covering an aggregate of 66,300 shares. The options have an exercise price per share equal to $11.25, the closing price of the Company’s American Depositary Shares on the Nasdaq Global Select Market on the grant date, and will vest over a four-year period with 25% vesting on the first anniversary of the date of the grant and the remaining 75% vesting in equal monthly installments over the three-year period thereafter, subject to each employee’s continued employment. The restricted
Clinilabs Announces Medical Leadership Appointments5.8.2026 16:05:00 CEST | Press release
Bob Dagher, M.D., Named Chief Medical Officer and Waqar Ahmed Siddiqui, M.D., Named Principal Investigator Clinilabs (“Clinilabs LLC”), a global, full-service contract research organization (CRO) specializing in central nervous system (CNS) drug and device development, today announced the appointments of Bob Dagher, M.D., as Chief Medical Officer and Waqar Ahmed Siddiqui, M.D., as Principal Investigator of the Company’s Eatontown, New Jersey Clinical Research Unit (CRU). Dr. Dagher will provide strategic and medical leadership across the organization, while Dr. Siddiqui will lead the execution of research projects at the Company’s CRU. Together, they will support the design, development, and execution of clinical programs for pharmaceutical, biotechnology, and medical device sponsors advancing innovative therapies for psychiatric, neurological, substance use, and rare CNS disorders. “Clinilabs has earned the trust of sponsors by combining deep scientific expertise, medical leadership,
Interactive Brokers Adds Brazilian Futures through Brazil’s B3 Exchange5.8.2026 16:00:00 CEST | Press release
Interactive Brokers (Nasdaq: IBKR), an automated global broker, today announced that eligible clients outside of Brazil can now trade Brazilian futures in addition to equities through the B3 exchange. Interactive Brokers was the first broker to provide international investors with streamlined, low-cost access to B3. Offering Brazilian futures and equities alongside products across more than 170 markets worldwide underscores IBKR’s commitment to broadening global market access and giving clients efficient, cost-effective ways to diversify through a single, unified platform. Access to B3 provides exposure to one of Latin America’s most active and liquid markets, providing long-term growth potential across multiple sectors and another way for investors to pursue emerging market opportunities. "Global investors deserve seamless, low-cost access to the world's most compelling markets, including emerging economies shaping tomorrow's financial landscape," said Milan Galik, Chief Executive Off
In our pressroom you can read all our latest releases, find our press contacts, images, documents and other relevant information about us.
Visit our pressroom
